Rule 17 disclosure
EDX Medical Group plc has issued a Rule 17 disclosure regarding its non-executive chairman, Jason Christopher Holt, who resigned as a director of European Cargo Limited (ECL) on September 5, 2025. ECL subsequently entered administration on June 3, 2026, though EDX Medical states there is no business relationship between the two entities.
Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes
CAMBRIDGE, UK: EDX Medical (TIDM: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer and infectious diseases, provides the following update pursuant to Rule 17 and Schedule 2g of the AIM Rules.
Jason Christopher Holt, non-executive chairman of EDX Medical, was a director of European Cargo Limited (ECL) and resigned that directorship on September 5, 2025. ECL subsequently entered into administration on June 3, 2026. There is no business relationship between EDX Medical and ECL.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.